Myriad Genetics's Earnings: A Preview

Myriad Genetics MYGN is set to give its latest quarterly earnings report on Tuesday, 2025-05-06. Here's what investors need to know before the announcement.

Analysts estimate that Myriad Genetics will report an earnings per share (EPS) of $-0.06.

Investors in Myriad Genetics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Overview of Past Earnings

Last quarter the company missed EPS by $0.00, which was followed by a 14.8% drop in the share price the next day.

Here's a look at Myriad Genetics's past performance and the resulting price change:

Myriad Genetics Share Price Analysis

Shares of Myriad Genetics were trading at $7.56 as of May 02. Over the last 52-week period, shares are down 61.02%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Myriad Genetics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.